Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 95-101

  Suzuki, Naoki ^a   Mizuno, Hideki ^a   Warita, Hitoshi ^a   Takeda, Shin'ichi ^b   Itoyama, Yasuto ^a   Aoki, Masashi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Motor neuron disease (MND); Muscle atrophy; Neuronal nitric oxide synthase (nNOS); Superoxide dismutase (SOD1)

Indexed keywords

ATROGIN 1; NEURONAL NITRIC OXIDE SYNTHASE; COPPER ZINC SUPEROXIDE DISMUTASE; FBXO32 PROTEIN, MOUSE; MESSENGER RNA; MUSCLE PROTEIN; NOS1 PROTEIN, HUMAN; NOS1 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; TRIM63 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DENERVATION; EXTRACTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUTANT; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SARCOLEMMA; TAIL; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; SKELETAL MUSCLE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYTOPLASM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NITRIC OXIDE SYNTHASE TYPE I; RNA, MESSENGER; SARCOLEMMA; SKP CULLIN F-BOX PROTEIN LIGASES; SUPEROXIDE DISMUTASE; UBIQUITIN-PROTEIN LIGASES;

EID: 77953287436     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.03.022     Document Type: Article

References (43)

1. Mitchell J.D., and Borasio G.D. Amyotrophic lateral sclerosis. Lancet 369 (2007) 2031-2041
2. Miller T.M., Smith R.A., and Cleveland D.W. Amyotrophic lateral sclerosis and gene therapy. Nat Clin Pract Neurol 2 (2006) 462-463
3. Pasinelli P., and Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7 (2006) 710-723
4. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
5. Aoki M., Abe K., Houi K., Ogasawara M., Matsubara Y., Kobayashi T., et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 37 (1995) 676-679
6. Aoki M., Ogasawara M., Matsubara Y., Narisawa K., Nakamura S., Itoyama Y., et al. Mild ALS in Japan associated with novel SOD mutation. Nat Genet 5 (1993) 323-324
7. Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21 (2001) 9246-9254
8. Sasaki S., Nagai M., Aoki M., Komori T., Itoyama Y., and Iwata M. Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene. J Neuropathol Exp Neurol 66 (2007) 517-524
9. Mizuno H., Warita H., Aoki M., and Itoyama Y. Accumulation of chondroitin sulfate proteoglycans in the microenvironment of spinal motor neurons in amyotrophic lateral sclerosis transgenic rats. J Neurosci Res 86 (2008) 2512-2523
10. Ishigaki A., Aoki M., Nagai M., Warita H., Kato S., Kato M., et al. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J Neuropathol Exp Neurol 66 (2007) 1037-1044
11. Tidball J.G. Mechanical signal transduction in skeletal muscle growth and adaptation. J Appl Physiol 98 (2005) 1900-1908
12. Ikemoto M., Nikawa T., Takeda S., Watanabe C., Kitano T., Baldwin K.M., et al. Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J 15 (2001) 1279-1281
13. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
14. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., and Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98 (2001) 14440-14445
15. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3 (2001) 1014-1019
16. Song Y.H., Li Y., Du J., Mitch W.E., Rosenthal N., and Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115 (2005) 451-458
17. Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3 (2001) 1009-1013
18. Latres E., Amini A.R., Amini A.A., Griffiths J., Martin F.J., Wei Y., et al. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280 (2005) 2737-2744
19. Cai D., Frantz J.D., Tawa Jr. N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119 (2004) 285-298
20. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
21. Li Y.P., Schwartz R.J., Waddell I.D., Holloway B.R., and Reid M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 12 (1998) 871-880
22. Acharyya S., Butchbach M.E., Sahenk Z., Wang H., Saji M., Carathers M., et al. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8 (2005) 421-432
23. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114 (2004) 370-378
24. Suzuki N., Motohashi N., Uezumi A., Fukada S., Yoshimura T., Itoyama Y., et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117 (2007) 2468-2476
25. Koyama S., Arawaka S., Chang-Hong R., Wada M., Kawanami T., Kurita K., et al. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem Biophys Res Commun 343 (2006) 719-730
26. Kato M., Aoki M., Ohta M., Nagai M., Ishizaki F., Nakamura S., et al. Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial amyotrophic lateral sclerosis with the homozygous mutation. Neurosci Lett 312 (2001) 165-168
27. Aoki M., Kato S., Nagai M., and Itoyama Y. Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene. Neuropathology 25 (2005) 365-370
28. Sasaki S., Aoki M., Nagai M., Kobayashi M., and Itoyama Y. Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene. J Neuropathol Exp Neurol 68 (2009) 365-373
29. Brenman J.E., Chao D.S., Xia H., Aldape K., and Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82 (1995) 743-752
30. Leger B., Vergani L., Soraru G., Hespel P., Derave W., Gobelet C., et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20 (2006) 583-585
31. Kato N., Sato S., Yokoyama H., Kayama T., and Yoshimura T. Sequential changes of nitric oxide levels in the temporal lobes of kainic acid-treated mice following application of nitric oxide synthase inhibitors and phenobarbital. Epilepsy Res 65 (2005) 81-91
32. Kim S.F., Huri D.A., and Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310 (2005) 1966-1970
33. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown Jr. R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42 (1997) 644-654
34. Cassina P., Peluffo H., Pehar M., Martinez-Palma L., Ressia A., Beckman J.S., et al. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 67 (2002) 21-29
35. Soraru G., Vergani L., Fedrizzi L., D'Ascenzo C., Polo A., Bernazzi B., et al. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. Neuropathol Appl Neurobiol 33 (2007) 204-211
36. Ikeda K., Iwasaki Y., and Kinoshita M. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the Wobbler mouse. J Neurol Sci 160 (1998) 9-15
37. Facchinetti F., Sasaki M., Cutting F.B., Zhai P., MacDonald J.E., Reif D., et al. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience 90 (1999) 1483-1492
38. Martinez J.A., Francis G.J., Liu W.Q., Pradzinsky N., Fine J., Wilson M., et al. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience 157 (2008) 908-925
39. Talman W.T., and Dragon D.N. Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase. Hypertension 43 (2004) 820-824
40. Yamaleyeva L.M., Gallagher P.E., Vinsant S., and Chappell M.C. Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2.Lewis rats. Am J Physiol Regul Integr Comp Physiol 292 (2007) R819-R826
41. Kakoki M., Zou A.P., and Mattson D.L. The influence of nitric oxide synthase 1 on blood flow and interstitial nitric oxide in the kidney. Am J Physiol Regul Integr Comp Physiol 281 (2001) R91-R97
42. Babu B.R., and Griffith O.W. N5-(1-Imino-3-butenyl)-l-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J Biol Chem 273 (1998) 8882-8889
43. Burkard N., Rokita A.G., Kaufmann S.G., Hallhuber M., Wu R., Hu K., et al. Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100 (2007) e32-e44